Description
Intended use — REDx™ SARS-CoV-2 Negative Control is an unassayed control intended to monitor laboratory testing performance, procedures, and workflow with nucleic acid tests (NATs) that detect SARS-CoV-2 in human nasopharyngeal, oropharyngeal, nasal mid-turbinate, anterior nares and lower respiratory samples.
Application — IVD Quality Control
Assay Compatibility — Nucleic acid testing
Format: Vial (0.5 mL)